Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 455901 - 455920 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (L04AB06) golimumab (adm: P) | Simponi | 1, 50 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Arthritis, Rheumatoid | Janssen-CilagAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 10, 20 mg/ml , Injektionsflaska, 1 x 10 ml (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | AbacusMedicineA/S |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 4, 20 mg/ml , Injektionsflaska, 1 x 4 ml (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | AbacusMedicineA/S |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 20, 20 mg/ml , Injektionsflaska, 1 x 20 ml (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | AbacusMedicineA/S |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 4, 20 mg/ml , Injektionsflaska, 1 x 4 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 20, 20 mg/ml , Injektionsflaska, 1 x 20 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 10, 20 mg/ml , Injektionsflaska, 1 x 10 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 10, 20 mg/ml , Injektionsflaska, 1 x 10 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 4, 20 mg/ml , Injektionsflaska, 1 x 4 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 20, 20 mg/ml , Injektionsflaska, 1 x 20 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 40, 20 mg/ml , Injektionsflaska, 4 x 10 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 80, 20 mg/ml , Injektionsflaska, 4 x 20 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 80, 20 mg/ml , Injektionsflaska, 4 x 20 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra® | 16, 20 mg/ml , Injektionsflaska, 4 x 4 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab (adm: P) | RoActemra | 4, 162 mg , Förfylld injektionspenna, 4 x 1 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheAB |
| Sweden | (L04AC21) bimekizumab (adm: P) | Bimzelx | 1, 320 mg , Förfylld injektionspenna, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | UCBNordicA/S |
| Sweden | (L04AD02) tacrolimus (adm: O) | Modigraf | 50, 0,2 mg , Dospåsar, 50 st | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | AstellasPharmaAB |
| Sweden | (L04AD02) tacrolimus (adm: O) | Modigraf | 50, 0,2 mg , Dospåsar, 50 st (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | MedartuumAB |
| Sweden | (L04AD02) tacrolimus (adm: O) | Modigraf | 50, 1 mg , Dospåsar, 50 st | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | AstellasPharmaAB |
| Sweden | (L04AD02) tacrolimus (adm: O) | Modigraf | 50, 1 mg , Dospåsar, 50 st (PD 2 Care 4 ApS) | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | 2care4ApS |
Pages
